Unique features of mutations revealed by sequentially reprogrammed induced pluripotent stem cells

Nature Communications

Volumn 6, Issue , 2015, Pages

  Gao, Shuai ^a,b   Zheng, Caihong ^c   Chang, Gang ^b   Liu, Wenqiang ^d   Kou, Xiaochen ^d   Tan, Kun ^a   Tao, Li ^a   Xu, Kai ^d   Wang, Hong ^d   Cai, Jun ^c   Tian, Jianhui ^a   Gao, Shaorong ^b,d  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

^c Chinese Academy of Sciences and China National Center for Bioinformation   (China)

^d TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACCUMULATION; CELL ORGANELLE; HETEROGENEITY; MUTATION; RODENT; STEM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA METHYLATION; EMBRYO; FEMALE; GENE SEQUENCE; GENETIC COMPLEMENTATION; GENETIC HETEROGENEITY; IN VITRO STUDY; MOUSE; MUTATION; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PROGENY; PROMOTER REGION; RNA SEQUENCE; SOMATIC MUTATION; TETRAPLOIDY; ADIPOCYTE; ANIMAL; BLASTOCYST; CROSS BREEDING; CYTOLOGY; FIBROBLAST; GENE DOSAGE; GENOME; INDUCED PLURIPOTENT STEM CELL; MALE; METABOLISM; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSGENIC MOUSE;

IPS; MUS;

ADIPOCYTES; ANIMALS; BLASTOCYST; CELL DIFFERENTIATION; CELLULAR REPROGRAMMING; CROSSES, GENETIC; FEMALE; FIBROBLASTS; GENE DOSAGE; GENOME; INDUCED PLURIPOTENT STEM CELLS; MALE; MICE; MICE, TRANSGENIC; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84923668835     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7318     Document Type: Article

References (67)

1. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
2. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
3. Park, I. H. et al. Disease-specific induced pluripotent stem cells. Cell 134, 877-886 (2008).
4. Soldner, F. et al. Parkinson's Disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964-977 (2009).
5. Takebe, T. et al. Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499, 481-484 (2013).
6. Yamanaka, S. A fresh look at iPS cells. Cell 137, 13-17 (2009).
7. Hou, P. et al. Pluripotent stem cells induced from mouse somatic cells by smallmolecule compounds. Science 341, 651-654 (2013).
8. Kato, Y. et al. Eight calves cloned from somatic cells of a single adult. Science 282, 2095-2098 (1998).
9. Wakayama, T., Perry, A. C., Zuccotti, M., Johnson, K. R. & Yanagimachi, R. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 394, 369-374 (1998).
10. Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J. & Campbell, K. H. Viable offspring derived from fetal and adult mammalian cells. Nature 385, 810-813 (1997).
11. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
12. Wakayama, S. et al. Successful serial recloning in the mouse over multiple generations. Cell Stem Cell 12, 293-297 (2013).
13. Boland, M. J. et al. Adult mice generated from induced pluripotent stem cells. Nature 461, 91-94 (2009).
14. Carey, B. W. et al. Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell 9, 588-598 (2011).
15. Kang, L., Wang, J. L., Zhang, Y., Kou, Z. H. & Gao, S. R. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 5, 135-138 (2009).
16. Stadtfeld, M. et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465, 175-181 (2010).
17. Young, M. A. et al. Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. Cell Stem Cell 10, 570-582 (2012).
18. Laurent, L. C. et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human escs and ipscs during reprogramming and time in culture. Cell Stem Cell 8, 106-118 (2011).
19. Gore, A. et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63-76 (2011).
20. Hussein, S. M. et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58-67 (2011).
21. Ji, J. F. et al. Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells. Stem Cells 30, 435-440 (2012).
22. Wakayama, T. et al. Ageing: cloning of mice to six generations. Nature 407, 318-319 (2000).
23. Kou, Z. H. et al. Mice cloned from induced pluripotent stem cells (iPSCs). Biol. Reprod. 83, 238-243 (2010).
24. Chang, G. et al. High-throughput sequencing reveals the disruption of methylation of imprinted gene in induced pluripotent stem cells. Cell Res. 24, 293-306 (2014).
25. Eppig, J. T. et al. The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse. Nucleic Acids Res. 40, 881-886 (2012).
26. Roelfsema, J. H. et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am. J. Hum. Genet. 76, 572-580 (2005).
27. Le Gallo, M. et al. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nat. Genet. 44, 1310-1315 (2012).
28. Peifer, M. et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat. Genet. 44, 1104-1110 (2012).
29. Zimmermann, N., Acosta, A. M., Kohlhase, J. & Bartsch, O. Confirmation of EP300 gene mutations as a rare cause of Rubinstein-Taybi syndrome. Eur. J. Hum. Genet. 15, 837-842 (2007).
30. Foley, P., Bunyan, D., Stratton, J., Dillon, M. & Lynch, S. A. Further case of Rubinstein-Taybi syndrome due to a deletion in EP300. Am. J. Med. Genet. A 149A, 997-1000 (2009).
31. Bartsch, O. et al. Two patients with EP300 mutations and facial dysmorphism different from the classic Rubinstein-Taybi syndrome. Am. J. Med. Genet. A 152A, 181-184 (2010).
32. Yao, T. P. et al. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93, 361-372 (1998).
33. Straub, R. E. et al. Allelic variation in GAD1 (GAD(67)) is associated with schizophrenia and influences cortical function and gene expression. Mol. Psychiatry 12, 854-869 (2007).
34. Laitinen, P. J. et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103, 485-490 (2001).
35. Priori, S. G. et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103, 196-200 (2001).
36. Tiso, N. et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum. Mol. Genet. 10, 189-194 (2001).
37. Kannankeril, P. J. et al. Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy. Proc. Natl Acad. Sci. USA 103, 12179-12184 (2006).
38. Lehnart, S. E. et al. Leaky Ca(2\+) release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. J. Clin. Invest. 118, 2230-2245 (2008).
39. Bhuiyan, Z. A. et al. Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features. Circulation 116, 1569-1576 (2007).
40. Zou, Y. Z. et al. Ryanodine receptor type 2 is required for the development of pressure overload-induced cardiac hypertrophy. Hypertension 58, 1099-1110 (2011).
41. Gigante, M. et al. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS). Nephrol. Dial. Transplant. 24, 1858-1864 (2009).
42. Benoit, G. et al. Analysis of recessive CD2AP and ACTN4 mutations in steroidresistant nephrotic syndrome. Pediatr. Nephrol. 25, 445-451 (2010).
43. Kim, J. M. et al. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300, 1298-1300 (2003).
44. Kuroda, R. et al. A novel compound heterozygous mutation in the DAP12 gene in a patient with Nasu-Hakola disease. J. Neurol. Sci. 252, 88-91 (2007).
45. Carvill, G. L. et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat. Genet. 45, 825-830 (2013).
46. Chenier, S. et al. CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems. J. Neurodev. Disord. 6, 9 (2014).
47. Abyzov, A. et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492, 438-442 (2012).
48. Pinheiro, L. B. et al. Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification. Anal. Chem. 84, 1003-1011 (2012).
49. Farkash-Amar, S. et al. Global organization of replication time zones of the mouse genome. Genome Res. 18, 1562-1570 (2008).
50. Hiratani, I. et al. Global reorganization of replication domains during embryonic stem cell differentiation. PLoS Biol. 6, 2220-2236 (2008).
51. Lu, J. et al. The distribution of genomic variations in human iPSCs is related to replication-timing reorganization during reprogramming. Cell Rep. 7, 70-78 (2014).
52. Lu, S. J. et al. Probing meiotic recombination and aneuploidy of single sperm cells by whole-genome sequencing. Science 338, 1627-1630 (2012).
53. Zong, C. H., Lu, S. J., Chapman, A. R. & Xie, X. S. Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science 338, 1622-1626 (2012).
54. Cheng, L. Z. et al. Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell 10, 337-344 (2012).
55. Quinlan, A. R. et al. Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming. Cell Stem Cell 9, 366-373 (2011).
56. Martins-Taylor, K. et al. Recurrent copy number variations in human induced pluripotent stem cells. Nat. Biotechnol. 29, 488-491 (2011).
57. Cahan, P. & Daley, G. Q. Origins and implications of pluripotent stem cell variability and heterogeneity. Nat. Rev. Mol. Cell Biol. 14, 357-368 (2013).
58. Schuster, A. T., Sarvepalli, K., Murphy, E. A. & Longworth, M. S. Condensin II subunit dCAP-D3 restricts retrotransposon mobilization in Drosophila somatic cells. PLoS Genet. 9, e1003879 (2013).
59. Zheng, B., Cao, B. H., Li, G. H. & Huard, J. Mouse adipose-derived stem cells undergo multilineage differentiation in vitro but primarily osteogenic and chondrogenic differentiation in vivo. Tiss. Eng. 12, 1891-1901 (2006).
60. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589-595 (2010).
61. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
62. Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009).
63. Roberts, A., Pimentel, H., Trapnell, C. & Pachter, L. Identification of novel transcripts in annotated genomes using RNA-Seq. Bioinformatics 27, 2325-2329 (2011).
64. Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
65. Tang, K. et al. Chip-based genotyping by mass spectrometry. Proc. Natl Acad. Sci. USA 96, 10016-10020 (1999).
66. Abyzov, A., Urban, A. E., Snyder, M. & Gerstein, M. CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing. Genome Res. 21, 974-984 (2011).
67. Chen, K. et al. BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat. Methods 6, 677-681 (2009).